These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29944110)

  • 1. Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.
    Beer K; Dai M; Howell S; Rijal P; Townsend AR; Lin Y; Wharton SA; Daniels RS; McCauley JW
    J Gen Virol; 2018 Aug; 99(8):1001-1011. PubMed ID: 29944110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
    Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
    J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.
    Huang JW; Yang JM
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S31. PubMed ID: 21342562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of monoclonal antibodies against the hemagglutinin of H3N2 influenza A viruses.
    Yang F; Zhu L; Liu F; Cheng L; Yao H; Wu N; Wu H; Li L
    Virus Res; 2022 Aug; 317():198815. PubMed ID: 35595011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
    Chiba S; Kong H; Neumann G; Kawaoka Y
    mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
    Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
    Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.
    Popova L; Smith K; West AH; Wilson PC; James JA; Thompson LF; Air GM
    PLoS One; 2012; 7(7):e41895. PubMed ID: 22848649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Epitopes and Residues Mediating the Potential Antigenic Drift of the Hemagglutinin-Esterase Protein of Influenza C Virus.
    Matsuzaki Y; Sugawara K; Furuse Y; Shimotai Y; Hongo S; Mizuta K; Nishimura H
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
    Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
    Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.
    Ushirogawa H; Naito T; Tokunaga H; Tanaka T; Nakano T; Terada K; Ohuchi M; Saito M
    BMC Infect Dis; 2016 Aug; 16():380. PubMed ID: 27503338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of HA1 domain of influenza A/H3N2 viruses isolated in Kenya during the 2007-2013 seasons reveal significant divergence from WHO-recommended vaccine strains.
    Nyang'au EM; Bulimo WD; Mobegi V; Opanda S; Magiri E
    Int J Infect Dis; 2020 Jun; 95():413-420. PubMed ID: 32276045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011.
    Huang P; Liang LJ; Hou NM; Zhang X; Su WZ; Yu SY; Zhang YH; Wu J; Chen WQ
    Epidemiol Infect; 2013 May; 141(5):1061-9. PubMed ID: 22827898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM; Naeve CW; Webster RG
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    Tewawong N; Prachayangprecha S; Vichiwattana P; Korkong S; Klinfueng S; Vongpunsawad S; Thongmee T; Theamboonlers A; Poovorawan Y
    PLoS One; 2015; 10(10):e0139958. PubMed ID: 26440103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2.
    Lee HK; Tang JW; Loh TP; Oon LL; Koay ES
    Infect Genet Evol; 2015 Aug; 34():292-7. PubMed ID: 26118307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of antigenic drift in influenza viruses: analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the hemagglutinin molecule.
    Webster RG; Laver WG; Air GM; Ward C; Gerhard W; van Wyke KL
    Ann N Y Acad Sci; 1980; 354():142-61. PubMed ID: 6164328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
    Wan H; Gao J; Yang H; Yang S; Harvey R; Chen YQ; Zheng NY; Chang J; Carney PJ; Li X; Plant E; Jiang L; Couzens L; Wang C; Strohmeier S; Wu WW; Shen RF; Krammer F; Cipollo JF; Wilson PC; Stevens J; Wan XF; Eichelberger MC; Ye Z
    Nat Microbiol; 2019 Dec; 4(12):2216-2225. PubMed ID: 31406333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.